Abstract
The FDA approves the second OTC naloxone - a step toward opioid crisis mitigation.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1097/js9.0000000000000677
Copy DOIJournal: International Journal of Surgery | Publication Date: Sep 4, 2023 |
Citations: 1 |
The FDA approves the second OTC naloxone - a step toward opioid crisis mitigation.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.